Francois-Xavier Lamy

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Metastatic Colorectal Cancer

Patient Reported

Top Venues

Journal of comparative effectiveness research

Pharmaceutical statistics

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Heiko Götte, Marietta Kirchner, Johannes Krisam, Arthur Allignol, Francois-Xavier Lamy, Armin Schueler, Meinhard Kieser
An adaptive design for early clinical development including interim decision for single-arm trial with external controls or randomized trial. Pharmaceutical statistics 21 (3) (2022)
Zarmina S Khankhel, Sarah Goring, Sarah Bobiak, Francois-Xavier Lamy, Dweeti Nayak, Jamie Garside, Emily S Reese, Nancy Schoenherr
Second-line treatments in advanced biliary tract cancer: systematic literature review of efficacy, effectiveness and safety. Future oncology (London, England) 18 (18) (2022)
Chris P Pescott, Emmanuelle Boutmy, Michael Batech, Philippe Ronga, Francois-Xavier Lamy
Real-world healthcare resource utilization and costs of weekly versus every-2-week cetuximab in metastatic colorectal cancer. Journal of comparative effectiveness research 10 (5) (2021)
Francois-Xavier Lamy, Michael Batech, Emmanuelle Boutmy, Philippe Ronga, Shaista Salim, Chris P Pescott
Comparative effectiveness of weekly versus every-2-weeks cetuximab in metastatic colorectal cancer in a US-insured population. Journal of comparative effectiveness research 9 (16) (2020)